New clues why gold standard treatment for bipolar disorder doesn’t work for majority of patients
Shame and pain: Lung cancer’s stigma exerts psychic and physical toll
5 January 2021Division of tongue tie: surgical complications
5 January 2021New clues why gold standard treatment for bipolar disorder doesn’t work for majority of patients
Lithium is considered the gold standard for treating bipolar disorder (BD), but nearly 70 percent of people with BD don’t respond to it. This leaves them at risk for debilitating, potentially life-threatening mood swings. Researchers at the Salk Institute have found that the culprit may lie in gene activity—or lack of it.
